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Objective/background: Early initiation of therapy in patients with tuberculosis is imperative
for its control. Conventional methods of susceptibility testing such as the proportion
method (PM) require visual detection and counting of colonies that takes up to 6 weeks.
Rapid and simple phenotypic methods that have been endorsed by the World Health
Organization can serve as alternatives.
Methods: In this study, we evaluated the colorimetric nitrate reductase assay, which utilizes
the detection of nitrate reduction as an indicator of growth much earlier compared with PM
(within 7–14 days). The susceptibility of 75 clinical isolates of Mycobacterium tuberculosis to
four first-line antitubercular drugs was tested by nitrate reductase assay and compared
with the standard PM. In this assay, inoculation was done on both drug-free and
drug-containing Lo¨wenstein–Jensen medium containing sodium nitrate. After incubation
for 7–14 days, reduction to nitrite was taken as an indicator of growth, which was detected
by color change on addition of Griess reagent.
Results: Agreement between nitrate reductase assay and PM was 100% for rifampicin,
97.30% for isoniazid, 93.30% for streptomycin, and 98.60% for ethambutol. Cost/isolate with
this assay was found to be approximately two times lesser than that of PM. All results were
obtained in 7–14 days by nitrate reductase assay, which was significantly rapid compared
with 42 days taken for obtaining results by PM.
Conclusion: Nitrate reductase assay can be used as a rapid and inexpensive method for
drug-susceptibility testing of M. tuberculosis for first-line antitubercular drugs without
compromising accuracy of standard methods.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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During the past two decades, the world has witnessed a
dramatic increase in the incidence of tuberculosis (TB),
particularly emergence of multidrug-resistant (MDR) strains
that pose a major threat to the TB control program. In 2014,
estimates indicated 480,000 new cases of MDR-TB worldwide
and approximately 190,000 deaths from MDR-TB. More than
half of these patients were in India, China, and the Russian
Federation [1]. Factors contributing to the recent outbreak
and continued spread of MDR-TB include upsurgence of
human immunodeficiency virus infection, insufficient control
procedures, and laboratory delays in identification and suscep-
tibility testing of Mycobacterium tuberculosis isolates [2,3]. This
emphasizes the need for rapid and cost-effective susceptibility
testing to first-line antitubercular drugs to diagnose and treat
MDR cases at the earliest. More than treating individual cases,
it will ensure rapid control of spread of MDR epidemic.
The globally accepted standard methods of drug-
susceptibility testing (DST) are the proportion method (PM),
the absolute concentration method, and the resistance ratio
method. These methods are based on visual detection of
slow-growing colonies of M. tuberculosis and can take up to
6 weeks that may be crucial for early initiation of intensive-
phase therapy and reduction of bacterial load in smear-
positive cases [4]. Liquid medium-based automated culture
systems such as the BACTEC 460 TB system [5], the mycobac-
terial growth indicator tube MGIT 960 [6], BacT/ALERT 3D [7],
or ESP culture system II [8] require expensive substrate and
equipment and are therefore not feasible in most developing
countries [9]. Molecular tools such as line probe assays and
Xpert MTB/RIF besides being expensive require expertise
and may not differentiate active infection by picking DNA
from even dead organisms [10]. Microscopic observation
DST, although rapid and cheap, requires detailed staff train-
ing [11–14]. Colorimetric liquid medium-based susceptibility
tests such as resazurin microtiter assay [15] and 3-(4,5-dime
thylthiazol-2-yl)-2,5-diphenyltetrazolium bromide [16] carry
a biohazard risk through aerosol formation. Therefore, there
is an urgent need for a test that is inexpensive, rapid, safer,
and simpler to perform yet not compromising the accuracy
of standard procedures. Nitrate reductase assay on solid med-
ium is a susceptibility test well suited for this purpose. It is a
noncommercial colorimetric assay where visual detection of
color change on addition of Griess reagent [17] makes the test
easy to interpret.
This study was aimed at comparing the indirect nitrate
reductase assay (INRA) with the indirect proportion method
(IPM) in terms of speed, cost, ease of performance, and accu-
racy for DST to first-line antitubercular drugs.
Materials and methods
The study was conducted over a period of 18 months from
October 15, 2013, to April 15, 2015, in the Department of
Microbiology, Sher-i-Kashmir Institute of Medical Sciences,
Srinagar, Kashmir, India. The study was approved by the
Institute’s Ethical Committee.Strains
Seventy-five isolates of M. tuberculosis obtained from various
clinical samples (sample distribution: 49 sputum, 8 bron-
choalveolar lavage, 6 pus, 5 urine, 2 ascitic fluid, 2 pleural
fluid, 1 cervical node aspiration fluid, 1 tracheal aspiration
fluid, and 1 cerebrospinal fluid) were included in the study.
The samples after decontamination were inoculated on
standard Lo¨wenstein–Jensen (LJ) medium and incubated at
37 C for 6 weeks. All the isolates obtained thus were
identified by standard biochemical tests [18]. DST was
performed using IPM and INRA on fresh (3–4-week old)
growths only.
Indirect proportion method
DST by IPM [18] on LJ media was performed at the following
final drug concentrations: isoniazid (INH) at 0.2 lg/mL, rifam-
picin (RIF) at 40.0 lg/mL, streptomycin (STM) at 4.0 lg/mL, and
ethambutol (EMB) at 2.0 lg/mL. In brief, two appropriate
dilutions of the bacilli, 102 and 104 dilutions (undiluted =
106–108 colony-forming units/mL), were inoculated on drug-
containing and drug-free media, to obtain countable colonies
on both media. One set of media bottles for testing one
culture consisted of five LJ slopes (1 for neat, 2 for 102, and
2 for 104) and eight LJ drug-containing slopes (2 each for
drugs INH, RIF, EMB, and STM, i.e., 1 each for 102 and 104
suspensions). Thus, a total of 13 LJ slopes were required.
Slopes were put in a stand at a very slight angle from the
horizontal plane and placed in an incubator at 37 C.
The reference strain H37Rv, which is susceptible to all stan-
dard anti-TB drugs, was used as susceptible control in each
batch of tests.
The first reading of observable growth was taken on the
28th day and final reading was taken on the 42nd day.
The colonies were counted only on the slopes seeded with
the lowest inoculum that produced growth. The average num-
ber of colonies obtained for the two control slopes indicated
the number of culturable particles contained in the inoculum.
The average number of colonies obtained for the drug-
containing slopes indicated the number of resistant bacilli
contained in the inoculum. The percentage resistance was
calculated as the ratio of the number of colonies on
the drug-containing media to those on the control medium.
If R P1%, the isolate was taken as resistant.
If the result of the reading made on the 28th day was
‘‘resistant,” no further reading of the test for that drug was
required: the strain was classified as resistant. If the result
at the 28th day was ‘‘sensitive,” a second reading was made
on the 42nd day: this provided the definitive result.
Indirect nitrate reductase assay
DST by the INRA [19] was performed on standard LJ media at
the final drug concentrations as mentioned in the ‘‘Indirect
Proportion Method” section: sodium nitrate in critical con-
centration of 1000 lg/mL was incorporated into all drug-free
and drug-containing media used for the assay. In brief,
Fig. 2 – Indirect nitrate reductase assay of test strain
showing no color change in drug-containing media;
sensitive to all the four drugs.
Fig. 3 – Indirect nitrate reductase assay of test strain
showing less-intense color change in streptomycin and
isoniazid as compared with drug-free control; sensitive to
all the four drugs.
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2.5 mL of 7H9 broth taken in a sterile Bijou bottle with six
glass beads. It was vortexed for 1 min and allowed to stand
for 5 min. The supernatant was then transferred to a new
sterile vial and left to sediment for 15 min. The turbidity
was set at 1 McFarland using 0.067 M phosphate buffer (pH
6.8) and labeled as ‘neat’. A 1:10 dilution was prepared from
neat and labeled as ‘S2’. Three drug-free tubes were
inoculated with 0.2 mL of S2 and four drug-containing
tubes with 0.2 mL of neat. All tubes were initially incubated
at 37 C for up to 7 days.
Reading of tubes
On the 7th day of incubation, Griess reagent was prepared
shortly before use by mixing one part of 50% (v/v) concen-
trated HCl with two parts of 0.2% (w/v) sulfanilamide and
two parts of 0.1% (w/v) n-1-naphthylethylenediamine
dihydrochloride; 0.5 mL of this reagent was added to one
drug-free medium of all the strains and observed for color
change. Color change to pink magenta was suggestive of
M. tuberculosis growth. This was followed by testing of four
drug-containing media of that particular strain.
Interpretation
An isolate was considered sensitive if there was no color
change in drug-containing tubes (Figs. 1 and 2) or the color
was lighter than the drug-free control (Fig. 3); however, they
were considered resistant if the color intensity in the drug-
containing media was the same or more compared with that
in the drug-free control (Fig. 4).
In the case of a negative result on a drug-free tube on the
7th day, the aforementioned procedure was repeated on the
10th and 14th days of incubation.
Chi-square test was used to detect significance and kappa
test was used to analyze the agreement between the two
tests.Fig. 1 – Indirect nitrate reductase assay of sensitive control;
H37Rv showing no color change in drug-containing
media.
Fig. 4 – Indirect nitrate reductase assay of test strain
showing similar color change in ethambutol as compared
with drug-free control; resistant to ethambutol.
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All the results obtained by INRA in our study were compared
with the results of IPM in terms of ease of performance, cost/
isolate, time to positivity, sensitivity, specificity, and accuracy
(Table 1).
Although the same media and equipment were required
for both the procedures, the amount of media, number of
bottles, dilutions of inoculums, persons required, time to
inoculate media, and time to incubate were significantly less
in INRA. In addition, the inoculation of media using a loop in
IPM was technically more demanding compared with simpler
inoculation using pipettes in INRA. In our study, it took us just
40 s to inoculate one strain in INRA compared with 2–3 min of
loop inoculation in IPM.
The cost/strain by INRA amounted to 14 INR (0.219 USD)
and by IPM it was 36 INR (0.56 USD). This excluded the cost
of the equipment already present in our laboratory; also the
manpower utilized in this study was not included in the cost
calculation for each strain.
Of the 75 isolates that were subjected to INRA during the
study period, 27 (36%) isolates gave positive results on the
7th day, 30 (40%) isolates on the 10th day, and 18 (24%) isolates
on the 14th day of incubation.
Of the 75 isolates, 70 tested sensitive and five tested resis-
tant to RIF by IPM. The results of INRA for RIF were similar to
those of IPM in all the isolates. Thus, a perfect agreement
with the gold-standard PM was observed for RIF.
For INH, one isolate, identified as being sensitive by the
PM, was falsely identified as resistant by INRA and one isolate
resistant by the PMwas falsely identified as sensitive by INRA.
Thus, INRA was found to be 97.30% accurate in comparison
with PM.
For STM, there were two false-positive and three false-
negative results. An accuracy of 93.30% was observed with
reference to PM.
For EMB, one of the seven isolates tested resistant by PM
was falsely identified as sensitive by INRA. However, no
false-positive result was found for EMB with INRA. Thus, an
accuracy of 98.6% reflected a strong association of the two
diagnostic methods for EMB.Table 1 – Sensitivity, specificity, PPV, NPV, and accuracy of INRA
Antitubercular drug IPM INRA Statistical
Sensitive Resistant Sensitivity
Rifampicin Sensitive 70 0 100
Resistant 0 5
Isoniazid Sensitive 63 1 90.90
Resistant 1 10
Streptomycin Sensitive 56 2 82.30
Resistant 3 14
Ethambutol Sensitive 68 0 85.70
Resistant 1 6
INRA = indirect nitrate reductase assay; IPM = indirect proportion methoDiscussion
In this study, for INRA, 76% of the isolates showed results by
10 days compared with 42 days required by PM, indicating
that the INRA is quite rapid. Our results were similar to the
results of various studies [20–25] where fresh 3–4-week-old
colonies were used for testing, as older cultures may result
in unreliable susceptibility test results.
Cost is an important factor in resource-constraint areas of
the world where most of the disease is prevalent. A
cost/isolate of 14 INR (0.22 USD) by INRA as compared with
36 INR (0.56 USD) by IPM and much higher costs required
for commercial and molecular assays emphasizes the need
of this simple colorimetric assay to be routinely used in labo-
ratories especially in low-income countries. The additional
equipment, media, and infrastructure required for INRA are
routinely present in most laboratories.
DST results of INRA to four first-line antitubercular drugs
in our study gave favorable results for INH and RIF, the two
most important first-line drugs for TB.
In our study, RIF had perfect agreement between the two
methods. This observation was concordant with many previ-
ous studies [22,24,26–30]. As RIF is the most important drug in
the treatment of TB and considered a surrogate marker for
detecting MDR-TB, the results obtained in our study further
validate the use of INRA as a routine method for screening
of MDR-TB.
A slightly low sensitivity of INH was seen in our study,
which was concordant with the studies conducted by
Montoro et al. [22], Martin et al. [23], Mengatto et al. [24],
Lemus et al. [26], Kumar et al. [30], and Poojary et al. [31].
The lower sensitivities to STM and EMB observed in our
study have also been reported by other authors [9,32,33]. This
might be overcome by adjusting the critical drug concentra-
tions used in the INRA test, although it is well-known that
STM and EMB are difficult drugs to test even by conventional
methods.
For treating TB, time to positivity of various tests is critical.
In our study, we observed that INRA is rapid compared with
IPM but both need an additional time of 3–4 weeks for
growing isolates from smear-positive clinical samples. Thisas compared with IPM.
analysis
(%) Specificity (%) PPV (%) NPV (%) Accuracy (%) K value
100 100 100 100 1
98.40 90.9 98.4 97.30 0.893
96.50 87.5 94.9 93.30 0.806
100 100 98.5 98.60 0.916
d; NPV = negative predictive value; PPV = positive predictive value.
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media can be eliminated by applying the nitrate reductase
assay directly on the clinical specimen. The time lag of 3–4
weeks between direct and indirect NRA is crucial for early
initiation of therapy for TB, especially in areas with high
prevalence of MDR cases.Conclusions
In conclusion, INRA was found to be rapid and inexpensive;
besides, it was easy to perform and interpret compared with
the gold-standard IPM. It could act as an effective alternative
to time-consuming or expensive methods of susceptibility
testing especially in resource-constraint settings carrying
maximum burden of TB.Conflicts of interest
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